Beltran Lab

You are here

News

Patient Derived Prostate Cancer Organoids to Advance Precision Medicine

Loredana Puca, Ph.D., and a team of scientists from the Beltran Lab and Englander Institute for Precision Medicine at Weill Cornell Medicine, developed tumor organoids that recapitulate neuroendocrine prostate cancer, a rare and aggressive disease.

Prostate Cancer Foundation Announces 2017 PCF Challenge Awards to Accelerate the Development of New Treatments for Advanced Prostate Cancer

WASHINGTON, D.C., October 5, 2017 – The Prostate Cancer Foundation (PCF) today announced awards totaling $7.5 million to fund new 2017 PCF Challenge Awards supporting international, cross-disciplinary teams of investigators conducting pioneering rese

Weill Cornell Medicine Awarded $11.3 Million Prestigious Grant for Prostate Cancer Research